$WAY

Why is Waystar stock sliding today?

Waystar Holding Corp (WAY) stock fell 4.1% in pre-market trading after Q3 earnings. Revenue rose 21% YoY to $325.6M, and adjusted EPS of $0.44 beat estimates. However, full-year 2026 revenue guidance missed expectations, with a midpoint of $1.282B below the $1.29B consensus. Analysts raised price targets but cited concerns over Q4 growth deceleration.

Original reporting
Published Nov 3, 2026, 1:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 1:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$WAY
Bearish
high confidence
Mentioned
$WAY
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$WAYBearishHigh
01

Why it matters

The guidance miss is the primary driver of the 4% pre‑market decline, with analysts noting the slowdown in Q4 growth expectations.

02

Market read

First report of Waystar's earnings and guidance miss; immediate price impact and short‑term trading opportunity.

03

What to watch

Potential upside from the backlog of large‑enterprise implementations and analyst price‑target upgrades.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Waystar reported Q3 revenue up 21% YoY and EPS beat, but guidance fell short, triggering a sell‑off.

Company-level read

Ticker impact

$WAYBearishHigh confidence
Context

Waystar shares slid 4.1% in pre‑open trading after Q3 earnings beat but a full‑year 2026 revenue guidance miss and a slower Q4 growth outlook.

Expected impact

likely continued downside as investors price in slower revenue growth.

Evidence & confidence

The article reports fresh guidance numbers that fell short of consensus and a clear market reaction, providing a concrete catalyst for further sell‑off.

Market effects

Healthcare payment software sector may face broader pressure as investors scrutinize slower growth guidance.

U.S. growth‑oriented software stocks could see modest weakness amid midterm election uncertainty.

Limited to U.S. markets; no immediate global ripple.

Counterpoint

The earnings beat and strong bookings could support a rebound if guidance is revised upward later.

Key entities

  • Waystar Holding Corp

    Healthcare payment software provider.

Related articles

$WAYHighAI 8/10

Waystar Holding Corp (WAY) Q3 2026 Earnings Call Highlights: Revenue Jumps 21% as AI Bookings Surge

Waystar Holding Corp (WAY) reported Q3 2026 revenue growth of 21% YoY, with adjusted EBITDA up 24% and a 43% margin. Bookings surged 25% YoY, including a major client win. AI innovations drove 43% of Q3 bookings. However, Q4 revenue growth is expected to slow to ~6%, with adjusted EBITDA declining sequentially due to top-line variability and AI investments. Iodine's performance-based pricing model delayed revenue recognition. Net revenue retention was 108%, at the lower end of historical range.

$WAYMed

Waystar: Q3 Earnings Snapshot

Waystar Holding Corp. (WAY) reported Q3 earnings of $31M, or 16 cents per share, beating estimates. Adjusted EPS was 44 cents. Revenue was $325.6M, also exceeding forecasts. The company expects full-year EPS of $1.63-$1.71 and revenue of $1.28B-$1.29B.

$WAYHighAI 8/10

What Waystar (WAY) Said on Its Q3 Earnings Call

Waystar (WAY) reported Q3 bookings for Iodine exceeded year-to-date plans by 74%, with $15M in Q3 bookings. The company launched an autonomous claim-resubmission feature, estimating it could resubmit up to $5B in rejected claims annually. Waystar lowered its full-year revenue forecast to $1.277B-$1.287B but raised adjusted EBITDA guidance to $543M-$549M. The company cited timing pressures for the revenue outlook adjustment.

$WAYHighAI 8/10

Waystar shares tumble 7% on weak fiscal 2026 guidance

Waystar Holding Corp (WAY) reported Q3 earnings of $0.44 per share, beating estimates, with revenue up 21% YoY to $325.6M. However, shares fell 7.3% on weak fiscal 2026 guidance, with projected EPS of $1.63-$1.71 and revenue of $1.277B-$1.287B, both below consensus. The company reported 10% net income margin and 43% adjusted EBITDA margin.